Search Results - irwin+chaiken

4 Results Sort By:
Cyclic Peptide Triazole Dual Site Inhibitors of HIV-1 Envelope gp120 Glycoproteins
Cyclic Peptide Triazole Dual Site Inhibitors of HIV-1 Envelope gp120 Glycoproteins16-1930*, 14-1731*, and 09-1100PFaculty Inventors: Irwin Chaiken, Professor of Biochemistry & Molecular Biology and Adel Ahmed Rashad, Research Assistant Professor of Biochemistry & Molecular BiologyPAGE TITLECyclic Peptide Triazole Dual Site Inhibitors of HIV-1...
Published: 1/22/2024   |   Inventor(s): Irwin Chaiken
Keywords(s):  
Category(s): Life Sciences, Pharmaceuticals & Therapeutics
Novel cyclic peptides and methods using same
NCS UPLOADED THROUGH THE MARKETING PROJECT 09-1100 TO COMBINE 16-1930, 14-1731 & 09-1100 PAGE TITLE Cyclic Peptide Triazole Dual Site Inhibitors of HIV-1 Envelope gp120 Glycoproteins PAGE SUMMARY Globally, there are about 37 million people living with HIV/AIDS and 1.2 million died from AIDS-related illnesses in 2014. In the US, over...
Published: 8/1/2024   |   Inventor(s): Irwin Chaiken, Adel Ahmed
Keywords(s):  
Category(s): Pharmaceuticals & Therapeutics, Pharmaceuticals & Therapeutics > Pharma: Infectious Disease
Compositions for promoting HIV-1 virolysis and methods using same
PAGE TITLE Compounds for promoting HIV-1 virolysis PAGE SUMMARY Globally, there are about 37 million people living with HIV/AIDS and 1.2 million died from AIDS-related illnesses in 2014. In the US, over 1.1 million live with HIV/AIDS and 50,000 new cases are reported each year. The HIV therapeutics market was valued at $14.3 billion in 2012...
Published: 8/1/2024   |   Inventor(s): Irwin Chaiken, Mark Contarino, Cameron Abrams, Adel Ahmed
Keywords(s):  
Category(s): Pharmaceuticals & Therapeutics, Pharmaceuticals & Therapeutics > Pharma: Infectious Disease
Compositions for inhibiting virus entry and promoting virolysis, and methods thereof
PAGE TITLE Overview PAGE SUMMARY Globally, there are about 37 million people living with HIV/AIDS and 1.2 million died from AIDS-related illnesses in 2014. In the US, over 1.1 million live with HIV/AIDS and 50,000 new cases are reported each year. The HIV therapeutics market was valued at $14.3 billion in 2012 and is expected to reach $16.3...
Published: 7/22/2024   |   Inventor(s): Irwin Chaiken, Elisabeth Papazoglou, Arangassery Bastian, Kantharaju (no Last Name)
Keywords(s):  
Category(s): Pharmaceuticals & Therapeutics, Pharmaceuticals & Therapeutics > Pharma: Infectious Disease